Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolamide vs linezolid in rifampicin-resistant pulmonary tuberculosis (PK, safety, efficacy)
ChiCTR2300074234Phase 4Recruiting
- Sponsor
- Beijing Chest Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of contezolid in Rifampicin-resistant pulmonary tuberculosis (RR-PTB) (2 arms), sponsored by Beijing Chest Hospital. Primary endpoint: Adverse events. Started Sep 2021; status: recruiting.
02
Drugs
contezolid
03
Conditions
Rifampicin-resistant pulmonary tuberculosis (RR-PTB)
Beyond the preview
Go deeper on ChiCTR2300074234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074234.